Promimic AB Asset Resilience Ratio
Promimic AB asset resilience ratio. Promimic AB (PRO) has an Asset Resilience Ratio of 8.62% as of December 2022. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See PRO defensive asset coverage days to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of Promimic AB (2019–2022)
Asset resilience ratio of Promimic AB from 2019 to 2022. This chart shows how Promimic AB's Asset Resilience Ratio has changed over time. Read Promimic AB (PRO) total liabilities for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down Promimic AB's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see PRO total asset value.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Skr0.00 | 0% |
| Short-term Investments | Skr8.00 Million | 8.62% |
| Total Liquid Assets | Skr8.00 Million | 8.62% |
Asset Resilience Insights
- Limited Liquidity: Promimic AB maintains only 8.62% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Promimic AB Industry Peers by Asset Resilience Ratio
Compare Promimic AB's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Shenzhen New Industries Biomedical
SHE:300832 |
Medical Devices | 9.95% |
|
Double Medical Technology Inc
SHE:002901 |
Medical Devices | 12.59% |
|
BMC Medical Co. Ltd. A
SHE:301367 |
Medical Devices | 44.96% |
|
Emvision Medical Devices Ltd
AU:EMV |
Medical Devices | 0.06% |
|
Hironic Co. Ltd
KQ:149980 |
Medical Devices | 17.42% |
|
DRGEM Corporation
KQ:263690 |
Medical Devices | 2.12% |
|
Oncosil Medical Ltd
AU:OSL |
Medical Devices | 0.00% |
|
Adherium Ltd
AU:ADR |
Medical Devices | 15.45% |
Promimic AB Asset Resilience Ratio by Year (2019–2022)
Promimic AB asset resilience ratio by year from 2019 to 2022. The table below shows the annual Asset Resilience Ratio data for Promimic AB.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2022-12-31 | 8.62% | Skr8.00 Million ≈ $860.93K |
Skr92.77 Million ≈ $9.98 Million |
+10.93pp |
| 2021-12-31 | -2.31% | Skr-743.00K ≈ $-79.96K |
Skr32.16 Million ≈ $3.46 Million |
-14.60pp |
| 2019-12-31 | 12.29% | Skr4.00 Million ≈ $430.48K |
Skr32.56 Million ≈ $3.50 Million |
-- |
About Promimic AB
Promimic AB (publ) manufactures, markets, and sells biomaterials for improved osseointegration for orthopedic and dental implants markets. It offers HAnano surface technology that combines various properties that are known to improve osseointegration into one unique surface modification. The company was incorporated in 2004 and is based in Mölndal, Sweden.